OPEN TO NEW MEDICATIONS

A determining factor for placing trials with IPS Research Company may be our patient population. The patients we encounter are generally open to accessing new medications that may have fewer side effects and greater efficacy. Many of our patients are newly or recently diagnosed and need access to treatments that may be difficult to obtain elsewhere.

Conducting a wide array of trials, allows us a large and diverse database from which to draw. Some additional and important information about our patients:

• The state of Oklahoma ranks 2nd in the nation of uninsured persons
• 1st in the nation in persons diagnosed with mental illness
• High incidence of allergens
• High rate of Pulmonary and Respiratory disease
• High rate of Diabetes